There has been a recent shortage of a number of menopausal hormone therapy (MHT) preparations and some of these have now been or soon will be resolved:
Oral MHT
Femoston 1/10 – resolved
Duavive – supply due to be resolved by end January 2022
Angeliq - resolved
Transdermal
Climara – resolved
Estradot 100 – resolved
Estradot 75 – supply due to be resolved by the early April
Estradot 50 – supply due to be resolved by the early February
Estradot 37.5 – supply due to be resolved by early April
Estradot 25 – resolved
Estalis Conti - resolved
Estalis Sequi 50/140 –supply due to be resolved by mid February
Estalis Sequi 50/250 –supply due to be resolved by mid February
Estraderm MX 50 – supply due to be resolved by end of April
Estraderm MX 100 - supply due to be resolved by end of April
Estrogel/Estrogel Pro – resolved
Please note that dates for supply have been sourced from either the pharmaceutical distributor or the TGA website and may change at any time.
